News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
FELLOWS DAVID A
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2021 |
4
| FELLOWS DAVID A (Director) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Granted 22,000 options to buy
@ $10.72, valued at
$235.8k
|
|
| 06/07/2019 |
4
| FELLOWS DAVID A (CEO) has filed a Form 4 on Nightstar Therapeutics plc|
Txns:
| Disposed/sold 617,090 shares
@ $25.5, valued at
$15.7M
Disposed/sold 220,000 options to buy
@ $14.24, valued at
$3.1M
Disposed/sold 271,100 options to buy
@ $14.74, valued at
$4M
|
|
| 04/03/2019 |
4
| FELLOWS DAVID A (CEO) has filed a Form 4 on Nightstar Therapeutics plc|
Txns:
| Sold 9,305 shares
@ $25.31, valued at
$235.5k
|
|
| 01/24/2019 |
4
| FELLOWS DAVID A (CEO) has filed a Form 4 on Nightstar Therapeutics plc|
Txns:
| Granted 271,100 options to buy
@ $14.74, valued at
$4M
|
|
| 01/09/2019 |
4
| FELLOWS DAVID A (CEO) has filed a Form 4 on Nightstar Therapeutics plc|
Txns:
| Sold 8,733 shares
@ $12.9808, valued at
$113.4k
|
|
|
|